Improving strategies for diagnosing ovarian cancer: a summary of the International Ovarian Tumor Analysis (IOTA) studies
In order to ensure that ovarian cancer patients access appropriate treatment to improve the
outcome of this disease, accurate characterization before any surgery on ovarian pathology …
outcome of this disease, accurate characterization before any surgery on ovarian pathology …
Ultrasound scanning of the pelvis and abdomen for staging of gynecological tumors: a review
D Fischerova - Ultrasound in obstetrics & gynecology, 2011 - Wiley Online Library
This Review documents examination techniques, sonographic features and clinical
considerations in ultrasound assessment of gynecological tumors. The methodology of …
considerations in ultrasound assessment of gynecological tumors. The methodology of …
Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and …
Objectives To develop a risk prediction model to preoperatively discriminate between
benign, borderline, stage I invasive, stage II-IV invasive, and secondary metastatic ovarian …
benign, borderline, stage I invasive, stage II-IV invasive, and secondary metastatic ovarian …
Predicting the risk of malignancy in adnexal masses based on the Simple Rules from the International Ovarian Tumor Analysis group
Background Accurate methods to preoperatively characterize adnexal tumors are pivotal for
optimal patient management. A recent metaanalysis concluded that the International …
optimal patient management. A recent metaanalysis concluded that the International …
Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery: prospective validation by IOTA group
Objectives To prospectively assess the diagnostic performance of simple ultrasound rules to
predict benignity/malignancy in an adnexal mass and to test the performance of the risk of …
predict benignity/malignancy in an adnexal mass and to test the performance of the risk of …
Validation of models to diagnose ovarian cancer in patients managed surgically or conservatively: multicentre cohort study
B Van Calster, L Valentin, W Froyman, C Landolfo… - Bmj, 2020 - bmj.com
Objective To evaluate the performance of diagnostic prediction models for ovarian
malignancy in all patients with an ovarian mass managed surgically or conservatively …
malignancy in all patients with an ovarian mass managed surgically or conservatively …
Artificial intelligence and machine learning in cancer research: a systematic and thematic analysis of the top 100 cited articles indexed in Scopus database
IH Musa, LO Afolabi, I Zamit, TH Musa… - Cancer …, 2022 - journals.sagepub.com
Introduction Cancer is a major public health problem and a global leading cause of death
where the screening, diagnosis, prediction, survival estimation, and treatment of cancer and …
where the screening, diagnosis, prediction, survival estimation, and treatment of cancer and …
[HTML][HTML] Validation of a second-generation multivariate index assay for malignancy risk of adnexal masses
RL Coleman, TJ Herzog, DW Chan, DG Munroe… - American journal of …, 2016 - Elsevier
Background Women with adnexal mass suspected of ovarian malignancy are likely to
benefit from consultation with a gynecologic oncologist, but imaging and biomarker tools to …
benefit from consultation with a gynecologic oncologist, but imaging and biomarker tools to …
Evaluating the risk of ovarian cancer before surgery using the ADNEX model: a multicentre external validation study
Background: The International Ovarian Tumour Analysis (IOTA) group have developed the
ADNEX (The Assessment of Different NEoplasias in the adneXa) model to predict the risk …
ADNEX (The Assessment of Different NEoplasias in the adneXa) model to predict the risk …
A perspective on ovarian cancer biomarkers: past, present and yet-to-come
FR Ueland - Diagnostics, 2017 - mdpi.com
The history of biomarkers and ultrasonography dates back over more than 50 years. The
present status of biomarkers used in the context of ovarian cancer is addressed. Attention is …
present status of biomarkers used in the context of ovarian cancer is addressed. Attention is …